The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8501812 B1

PDF
Full Text
Expired
Date of Patent:
Aug. 06, 2013

Filed:

Mar. 01, 2011
Applicants:

Roger J. Davis, Princeton, MA (US);

Anja Jaeschke, Worcester, MA (US);

Inventors:

Roger J. Davis, Princeton, MA (US);

Anja Jaeschke, Worcester, MA (US);

Assignee:

University of Massachusetts, Boston, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/18 (2006.01); A61K 31/54 (2006.01); A61K 31/535 (2006.01); A61K 31/497 (2006.01); A61K 31/445 (2006.01); A61K 31/44 (2006.01); A61K 31/40 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to the treatment and prevention of type I diabetes. More specifically, the invention relates to compounds that treat or prevent the body's immune system from destroying β-cells (i.e., insulin-producing cells in the pancreatic islets of Langerhans) by inhibition of JNK2, selective inhibition of JNK2, or inhibition of the expression of the MAPK9 gene or gene product. In one embodiment, the present invention contemplates the diagnosis, identification, production, and use of compounds which modulate MAPK9 gene expression or the activity of the MAPK9 gene product including but not limited to, JNK2, the nucleic acid encoding MAPK9 and homologues, analogues, and deletions thereof, as well as antisense, ribozyme, triple helix, antibody, and polypeptide molecules as well as small inorganic molecules. The present invention contemplates a variety of pharmaceutical formulations and routes of administration for such compounds.


Find Patent Forward Citations

Davis, Roger. (2013). Therapeutic methods for type i diabetes (U.S. Patent No. 8501812). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8501812

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…